235 related articles for article (PubMed ID: 35156025)
1. Determination of Vitamin D Levels in Patients With Neurofibromatosis Type 1 in the Pediatric Age Group.
Santos A; Geller M; Mezitis S; Rubenstein AE; Oliveira L; Medeiros Lima DJ; Suchmacher Neto M; Nigri R; Cunha KGS; Takirambudde S; Gonçalves Ribeiro M
Clin Pathol; 2020; 13():2632010X20928930. PubMed ID: 35156025
[TBL] [Abstract][Full Text] [Related]
2. Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and familial neurofibromatosis 1 Brazilian adults: a cross-sectional study.
Basto DL; de Souza Vieira G; Andrade-Losso RM; Almeida PN; Riccardi VM; Rozza-de-Menezes RE; Cunha KS
Orphanet J Rare Dis; 2022 Sep; 17(1):341. PubMed ID: 36064430
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1.
Lammert M; Friedman JM; Roth HJ; Friedrich RE; Kluwe L; Atkins D; Schooler T; Mautner VF
J Med Genet; 2006 Oct; 43(10):810-3. PubMed ID: 16571643
[TBL] [Abstract][Full Text] [Related]
4. Analysis of neurofibromatosis 1 (NF1) lesions by body segment.
Palmer C; Szudek J; Joe H; Riccardi VM; Friedman JM
Am J Med Genet A; 2004 Mar; 125A(2):157-61. PubMed ID: 14981716
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor expression and serum 25(OH)D concentration inversely associates with burden of neurofibromas.
Kluwe L; Hagel C; Friedrich RE; Schnabel C; Schön G; Mautner V
Eur J Cancer Prev; 2019 May; 28(3):220-224. PubMed ID: 30299316
[TBL] [Abstract][Full Text] [Related]
6. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis without Neurofibromas: Confirmation of a Genotype-Phenotype Correlation and Implications for Genetic Testing.
Quintáns B; Pardo J; Campos B; Barros F; Volpini V; Carracedo A; Sobrido MJ
Case Rep Neurol; 2011 Apr; 3(1):86-90. PubMed ID: 21532985
[TBL] [Abstract][Full Text] [Related]
8. [Neurofibromas in Type I Neurofibromatosis. Description of a clinical case and literature review].
Del Puerto C; Aspee M; Downey C
Andes Pediatr; 2022 Oct; 93(5):741-748. PubMed ID: 37906895
[TBL] [Abstract][Full Text] [Related]
9. Differences of 25-hydroxyvitamin D3 concentrations in children and adults with neurofibromatosis type 1.
Schnabel C; Dahm S; Streichert T; Thierfelder W; Kluwe L; Mautner VF
Clin Biochem; 2014 May; 47(7-8):560-3. PubMed ID: 24613576
[TBL] [Abstract][Full Text] [Related]
10. [Managing children with neurofibromatosis type 1: what should we look for?].
Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1.
Modica R; Altieri B; D'Aniello F; Benevento E; Cannavale G; Minotta R; Liccardi A; Colao A; Faggiano A
Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837874
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and disease severity in patients with mosaic neurofibromatosis type 1: a single-center study and literature review.
Ejerskov C; Raundahl M; Gregersen PA; Handrup MM
Orphanet J Rare Dis; 2021 Apr; 16(1):180. PubMed ID: 33853649
[TBL] [Abstract][Full Text] [Related]
13. [Imaging features of neurofibromatosis type 1].
Jacques C; Dietemann JL
J Neuroradiol; 2005 Jun; 32(3):180-97. PubMed ID: 16134300
[TBL] [Abstract][Full Text] [Related]
14. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and follow-up protocol for adult patients with neurofibromatosis type 1 in a Spanish reference unit.
Solares I; Vinal D; Morales-Conejo M
Rev Clin Esp (Barc); 2022 Oct; 222(8):486-495. PubMed ID: 35688675
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.
Legius E; Brems H
Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904
[TBL] [Abstract][Full Text] [Related]
18. High frequencies of plexiform neurofibromas, mental retardation, learning difficulties, and scoliosis in Brazilian patients with neurofibromatosis type 1.
Trovó-Marqui AB; Goloni-Bertollo EM; Valério NI; Pavarino-Bertelli EC; Muniz MP; Teixeira MF; Antonio JR; Tajara EH
Braz J Med Biol Res; 2005 Sep; 38(9):1441-7. PubMed ID: 16138229
[TBL] [Abstract][Full Text] [Related]
19. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
